Formulation and evaluation of floating tablets of liquorice extract

Pharmacognosy Research

Volumn 2, Issue 5, 2010, Pages 304-308

  Aswatha Ram, H N ^a   Lachake, Prachiti ^a   Kaushik, Ujjwal ^a   Shreedhara, C S ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Buoyancy time; floating tablets; korsemeyer; liquorice extract

Indexed keywords

BICARBONATE; GLYCYRRHIZA GLABRA EXTRACT; MAGNESIUM STEARATE; TALC;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; GLYCYRRHIZA GLABRA; HELICOBACTER PYLORI; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; IN VITRO STUDY; NONHUMAN; PHYSICAL PARAMETERS; STOMACH ULCER;

EID: 78649496861     PISSN: None     EISSN: 09748490     Source Type: Journal    
DOI: 10.4103/0976-4836.72329     Document Type: Article

References (15)

1. Garg R, Gupta GD. Progress in controlled gastrointestinal delivery systems. Tropic J Pharm Res 2008;7:1055-66.
2. Indian Herbal Pharmacopoeia. Vol. 1. Indian Drug Manufacturer's Association and Regional Research Laboratory. Jammu Tawi Mumbai: Regional Research Laboratory; 1998. p. 89-97.
3. Bennet A, Melhuish PB, Stanmford IF. Carbenoxolone and deglycyrrhized liquorice have little or no effect on prostanoid synthesis by rat gastric mucosa ex vivo. Br J Pharmacol 1985;86:693-5.
4. Yano S, Harada M, Watanabe K, Hatakeyama Y, Shibata S, Takahashi K, et al. Antiulcer activities of glycyrrhetinic acid derivatives in experimental gastric lesion models. Chem Pharm Bull 1989;37:2500-4. (Pubitemid 19251637)
5. Adel M, Alousi LA, Salem HA. Licorice: A possible anti-infammatory and anti-ulcer drug. AAPS Pharm Sci Tech 2005;6:74-82.
6. Masoomeh MJ, Kiarash G. In vitro susceptibility of Helicobacter pylori to licorice extract. Iran. J Pharm Res 2007;6:69-72. (Pubitemid 351699343)
7. Rajpal V. Standardization of botanicals: Testing and extraction methods of medicinal herbs. Vol. 1. New Delhi: Eastern Publishers; 2002. p. 115-39.
8. Basak SC, Rao KN, Manavalan R, Rao PR. Development and in vitro evaluation of an oral foating matrix tablet formulation of ciprofoxacin. Indian J Pharm Sci 2004;66:313-6.
9. Wagner JG. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci 1969;58:1253-7.
10. Higuchi WI. Diffusional models useful in biopharmaceutics-Drug release rate processes. J Pharm Sci 1967;56:315.
11. Peppas NA, Ritger PL. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release 1987;5:37.
12. Timmermans J, Andre JM. Factors controlling the buoyancy and gastric retention capabilities of foating matrix capsules: New data for reconsidering the controversy. J Pharm Sci 1994;83:18-24. (Pubitemid 24233723)
13. Patel VF, Patel NM, Yeole PG. Studies on formulation and evaluation of ranitidine foating tablets. Indian J Pharm Sci 2005;67:703-9.
14. Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: A review. AAPS Pharm Sci Tech 2005;6:372-90. (Pubitemid 41631780)
15. nd ed. Pune: Nirali Prakashan; 2002. p. 149-51.